ZNTL — Zentalis Pharmaceuticals Share News
0.000.00%
Last trade - 00:00Brief: Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
U.S. STOCKS ON THE MOVE-Sun Communities, Cisco Systems, Paysafe
U.S. STOCKS ON THE MOVE-Fox, Sun Communities, Reddit, drone firms
U.S. STOCKS ON THE MOVE-Boost Run, Nektar Therapeutics, Swarmer
U.S. STOCKS ON THE MOVE-Reddit, Capricor Therapeutics, Birkenstock
Zentalis Pharma falls on $81 mln stock sale
Brief: Zentalis Pharmaceuticals Announces Pricing Of Underwritten Public Offering
Brief: Zentalis Pharmaceuticals Announces Proposed Underwritten Public Offering
Zentalis Pharma falls after starting stock offering
Zentalis Q2 net loss widens on higher R&D costs
Zentalis Pharmaceuticals Inc expected to post a loss of 49 cents a share - Earnings Preview
Brief: Zentalis Strengthens Commercial Leadership With Appointments Of Shannon Campbell To Board Of Directors And Sarah Kelly As SVP Of Commercial Strategy
Zentalis Q1 net loss narrows as operating expenses fall
Brief: Zentalis Pharmaceuticals Reports First Quarter 2026 Financial Results And Clinical Progress
Brief: Zentalis Pharmaceuticals Announces First Patient Dosed In Aspenova Phase 3 Trial Of Azenosertib In Patients With Cyclin E1-Positive Platinum-Resistant Ovarian Cancer
Brief: Zentalis Pharmaceuticals Announces 400Mg Qd 52 Azenosertib Monotherapy As The Pivotal Study Dose In Cyclin E1-Positive Platinum-Resistant Ovarian Cancer
Brief: Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
NASDAQ RESUMED AT 09:44 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:35 AM